Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Amiodarone EP Impurity F

Amiodarone EP Impurity F

147030-50-0

DISCOVER
Adamantanamine-1

Adamantanamine-1

768-94-5

DISCOVER
Amfepramone HCl

Amfepramone HCl

134-80-5

DISCOVER
Ethyl 4-Aminobenzoate

Ethyl 4-Aminobenzoate

94-09-7

DISCOVER
Acardit II

Acardit II

13114-72-2

DISCOVER
Atorvastatine Imp A

Atorvastatine Imp A

433289-83-9

DISCOVER
1-Hydroxyanthraquinone

1-Hydroxyanthraquinone

129-43-1

DISCOVER
Benzimidazol

Benzimidazol

51-17-2

DISCOVER
Benzyl benzoate

Benzyl benzoate

120-51-4

DISCOVER
Bromhexine HCL

Bromhexine HCL

611-75-6

DISCOVER
Bezafibrate

Bezafibrate

41859-67-0

DISCOVER
Bromazepam

Bromazepam

1812-30-2

DISCOVER